Saturday, August 29, 2009

ARNA reaches another milestone

One of Arena Pharmaceuticals' compounds just passed another milestone, completing Phase I clinical trials for type 2 diabetes mellitus patients.

Johnson and Johnson is the big pharma partner completing the clinical trials. Arena will receive milestone payments as well as a royalty split upon commercialization of the drug compound.

This is more evidence that ARNA has a strong drug pipeline beyond just Lorcaserin.

No comments:

Post a Comment